By Irena Royzman, Hannah Lee and Shannon Gillespie McComb ( January 7, 2022, 12:39 PM EST) -- On Sept. 21, 2021, the U.S. District Court for the District of Delaware granted summary judgment that two formulation patents were directed to patent-ineligible subject matter.[1] The two ChromaDex patents concern compositions and pharmaceutical formulations of nicotinamide riboside, or NR, a vitamin present in cow's milk, for oral administration....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.